The effect of non-depolarizing neuromuscular blocking agents on the release of acetylcholine from the right atrium of the guinea pig.
The effect of various non-depolarizing neuromuscular blocking agents (gallamine, pancuronium, vecuronium, d-tubocurarine, metocurine, atracurium and pipecuronium) on [3H]acetylcholine release in the response to field electrical stimulation was investigated in vitro in preparations of the guinea pig right atrium. In this preparation, atropine enhanced and oxotremorine, a muscarinic agonist, reduced the release of [3H] acetylcholine. Atropine reversed the inhibitory effect of oxotremorine in a concentration dependent manner, indicating that there is negative feedback modulation of acetylcholine release from the vagal nerve. While pancuronium, gallamine and atracurium enhanced the release of [3H]acetylcholine, d-tubocurarine, metocurine, vecuronium and pipecuronium did not affect it. Pancuronium and gallamine also reduced the inhibitory effect of oxotremorine and the Kd value of pancuronium for muscarinic receptors located on cholinergic nerve terminals was 2.31 microM. These findings indicate that pancuronium and gallamine enhanced the release of acetylcholine from the atrial parasympathetic nerve, probably by inhibiting presynaptic muscarinic receptors.
Manabe
N
N
Department of Anesthesiology and Rescusitology, Okayama University Medical School, Japan.
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001279:Atracurium / Q000494:pharmacology; D016280:Atrial Function, Right / Q000502:physiology; D004558:Electric Stimulation; D005260:Female; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D010197:Pancuronium / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000502:physiology; D017300:Pipecuronium / Q000494:pharmacology; D011976:Receptors, Muscarinic / Q000502:physiology; D014403:Tubocurarine / Q000031:analogs & derivatives / Q000494:pharmacology; D014673:Vecuronium Bromide / Q000494:pharmacology
D003473:Neuromuscular Nondepolarizing Agents; D011976:Receptors, Muscarinic; D017300:Pipecuronium; D001279:Atracurium; D014673:Vecuronium Bromide; D010197:Pancuronium; D000109:Acetylcholine; D005703:Gallamine Triethiodide; C032943:metocurine; D014403:Tubocurarine